Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
KKringle Pharma,Inc. logo
4884TSE Growth

Kringle Pharma,Inc.

クリングルファーマ Yahoo Finance

Recent & upcoming events

Aug 10
Earnings 2:00
Q3 earnings announcement (scheduled)
Add to Google Calendar
May 11
Earnings 2:00
Q2 earnings announcement (scheduled)
Add to Google Calendar
Feb 9
Earnings 1:00
Q1 earnings announcement (scheduled)
Add to Google Calendar
2025
Dec 22
Shareholder meeting Time TBD
Shareholders' meeting
Add to Google Calendar
Nov 12
Earnings 1:00
FY earnings announcement (scheduled)
Add to Google Calendar
Nov 9
Est.
Earnings 1:00 approx.
Full-year earnings
Add to Google Calendar
2027
Feb 8
Est.
Earnings 1:00 approx.
Q1 earnings
Add to Google Calendar
May 10
Est.
Earnings 2:00 approx.
Q2 earnings
Add to Google Calendar
Aug 9
Est.
Earnings 2:00 approx.
Q3 earnings
Add to Google Calendar

KPI highlights

FY25
Revenue ¥72M YoY -9.8%
Operating income ¥-909M margin -1259.4%
Net income ¥-916M YoY —
EPS ¥-134 EPS is sourced from a different data provider than net income (for reference)
P/E —
ROE —

Company guidance

FY2026/09 Company-issued full-year guidance (from earnings report) / %=vs prior FY
Revenue ¥332M +359.7%
Operating income ¥-1.02B —
Net income ¥-1.02B —
EPS ¥-132 —

Quarterly fundamentals

Income & cash flow
Quarter FY23 Q1FY23 Q2FY23 Q3FY23 Q4FY24 Q1FY25 Q4
Revenue ¥17M¥17M¥18M¥19M¥24M—
Operating income ¥-157M¥-306M¥-268M¥-169M¥-198M—
Net income ¥-158M¥-263M¥-276M¥-169M¥-197M—
Operating CF ——————

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2021–2025）

事業法人 16.2%海外機関 3.5%個人 5.6%未開示 74.8%20212022202320242025
事業法人国内機関海外機関個人未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

日本全薬工業株式会社 7.1%日本全薬工業株式会社STATE STREET BANK 3.5%STATE STREET BANK AND TRUST COMPANY 510643（常任代理人　株式会社みずほ銀行決済営業部）CYBERDYNE株式会社 2.9%CYBERDYNE株式会社山田　哲夫 2.5%山田　哲夫野村證券株式会社 1.7%野村證券株式会社高山　二郎 1.7%高山　二郎上田八木短資株式会社 1.6%上田八木短資株式会社丸石製薬株式会社 1.4%丸石製薬株式会社株式会社リプロセル 1.4%株式会社リプロセル安達　喜一 1.3%安達　喜一20212022202320242025

Top shareholders — actual figures (as of 2025)

Holder Shares held Ratio Source
日本全薬工業株式会社 500,840 7.1% Yuho (EDINET)
STATE STREET BANK AND TRUST COMPANY 510643 246,700 3.5% Yuho (EDINET)
CYBERDYNE株式会社 200,000 2.9% Yuho (EDINET)
山田 哲夫 177,000 2.5% Yuho (EDINET)
野村證券株式会社 122,050 1.7% Yuho (EDINET)
高山 二郎 120,300 1.7% Yuho (EDINET)
上田八木短資株式会社 111,800 1.6% Yuho (EDINET)
丸石製薬株式会社 100,000 1.4% Yuho (EDINET)
株式会社リプロセル 100,000 1.4% Yuho (EDINET)
安達 喜一 93,400 1.3% Yuho (EDINET)

Source：EDINET（大株主の状況）　Classification inferred from disclosed names

F-Score (Piotroski)

2/9 2 of 9 items lack data

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✗ Positive ROA ROA -44.1%
✗ Positive operating cash flow ¥-848M
✗ ROA improved YoY -27.4% → -44.1%
✓ Operating CF exceeds net income (accrual quality) OCF ¥-848M / net income ¥-916M
✗ Equity ratio improved* Substitute for the original “decrease in long-term debt” 76.5% → 63.0%
— Current ratio improved No data
✗ No dilution (shares outstanding did not increase) 6,810,700 → 7,018,200
— Gross margin improved No data
✓ Asset turnover improved 0.03× → 0.03×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY25
Equity ratio —
Current ratio —
Years of positive operating CF 0 of last 6 yrs
Payout ratio 0%
Latest fiscal year result Loss (net loss ¥916M)

Performance history

Last 10 years
0億円1億円2億円4億円5億円 FY20FY21FY22FY23FY24FY25

Income & assets

Unit: ¥100M
Item FY20FY21FY22FY23FY24FY25
Revenue 4.682.903.920.690.800.72
Operating income -1.72-3.58-4.26-8.89-8.18-9.09
Ordinary income -1.16-3.00-3.30-8.53-7.55-9.15
Net income -1.18-3.01-3.32-8.54-7.56-9.16
Total assets 23.526.432.126.227.620.8
Equity 21.925.127.920.221.113.1

Indicators & cash flow

Unit: ¥100M
Item FY20FY21FY22FY23FY24FY25
EPS ¥-107¥-73¥-68¥-158¥-118¥-134
ROE ——————
Operating CF -2.47-5.77-4.07-9.63-6.38-8.48
Investing CF ——-2.54-1.21-1.21-1.54
Financing CF 20.85.966.030.698.380.84
FCF -1.46-5.610.16-6.89-6.61-7.56

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Source: EDINET (Annual Securities Report) (fetched 2026-08-29) *Some metrics supplemented from additional sources

Sector positioning

Relative standing within the sector

IR disclosure history

Timely disclosures & annual reports
Is this information incorrect?

Data provided by Twelve Data